Cargando…
Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset
Pyrrole-imidazole (PI) polyamides are novel gene silencers that strongly bind the promoter region of target genes in a sequence-specific manner to inhibit gene transcription. We created a PI polyamide targeting human TGF-β1 (hTGF-β1). To develop this PI polyamide targeting hTGF-β1 (Polyamide) as a p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749436/ https://www.ncbi.nlm.nih.gov/pubmed/31480595 http://dx.doi.org/10.3390/molecules24173178 |
_version_ | 1783452278392356864 |
---|---|
author | Otsuki, Masari Fukuda, Noboru Inoue, Takashi Mineshige, Takayuki Otsuki, Tomoyasu Horikoshi, Shu Endo, Morito Abe, Masanori |
author_facet | Otsuki, Masari Fukuda, Noboru Inoue, Takashi Mineshige, Takayuki Otsuki, Tomoyasu Horikoshi, Shu Endo, Morito Abe, Masanori |
author_sort | Otsuki, Masari |
collection | PubMed |
description | Pyrrole-imidazole (PI) polyamides are novel gene silencers that strongly bind the promoter region of target genes in a sequence-specific manner to inhibit gene transcription. We created a PI polyamide targeting human TGF-β1 (hTGF-β1). To develop this PI polyamide targeting hTGF-β1 (Polyamide) as a practical medicine for treating progressive renal diseases, we examined the effects of Polyamide in two common marmoset models of nephropathy. We performed lead optimization of PI polyamides that targeted hTGF-β1 by inhibiting in a dose-dependent manner the expression of TGF-β1 mRNA stimulated by PMA in marmoset fibroblasts. Marmosets were housed and fed with a 0.05% NaCl and magnesium diet and treated with cyclosporine A (CsA; 37.5 mg/kg/day, eight weeks) to establish chronic nephropathy. We treated the marmosets with nephropathy with Polyamide (1 mg/kg/week, four weeks). We also established a unilateral urethral obstruction (UUO) model to examine the effects of Polyamide (1 mg/kg/week, four times) in marmosets. Histologically, the renal medulla from CsA-treated marmosets showed cast formation and interstitial fibrosis in the renal medulla. Immunohistochemistry showed strong staining of Polyamide in the renal medulla from CsA-treated marmosets. Polyamide treatment (1 mg/kg/week, four times) reduced hTGF-β1 staining and urinary protein excretion in CsA-treated marmosets. In UUO kidneys from marmosets, Polyamide reduced the glomerular injury score and tubulointerstitial injury score. Polyamide significantly suppressed hTGF-β1 and snail mRNA expression in UUO kidneys from the marmosets. Polyamide effectively improved CsA- and UUO-associated nephropathy, indicating its potential application in the prevention of renal fibrosis in progressive renal diseases. |
format | Online Article Text |
id | pubmed-6749436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67494362019-09-27 Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset Otsuki, Masari Fukuda, Noboru Inoue, Takashi Mineshige, Takayuki Otsuki, Tomoyasu Horikoshi, Shu Endo, Morito Abe, Masanori Molecules Article Pyrrole-imidazole (PI) polyamides are novel gene silencers that strongly bind the promoter region of target genes in a sequence-specific manner to inhibit gene transcription. We created a PI polyamide targeting human TGF-β1 (hTGF-β1). To develop this PI polyamide targeting hTGF-β1 (Polyamide) as a practical medicine for treating progressive renal diseases, we examined the effects of Polyamide in two common marmoset models of nephropathy. We performed lead optimization of PI polyamides that targeted hTGF-β1 by inhibiting in a dose-dependent manner the expression of TGF-β1 mRNA stimulated by PMA in marmoset fibroblasts. Marmosets were housed and fed with a 0.05% NaCl and magnesium diet and treated with cyclosporine A (CsA; 37.5 mg/kg/day, eight weeks) to establish chronic nephropathy. We treated the marmosets with nephropathy with Polyamide (1 mg/kg/week, four weeks). We also established a unilateral urethral obstruction (UUO) model to examine the effects of Polyamide (1 mg/kg/week, four times) in marmosets. Histologically, the renal medulla from CsA-treated marmosets showed cast formation and interstitial fibrosis in the renal medulla. Immunohistochemistry showed strong staining of Polyamide in the renal medulla from CsA-treated marmosets. Polyamide treatment (1 mg/kg/week, four times) reduced hTGF-β1 staining and urinary protein excretion in CsA-treated marmosets. In UUO kidneys from marmosets, Polyamide reduced the glomerular injury score and tubulointerstitial injury score. Polyamide significantly suppressed hTGF-β1 and snail mRNA expression in UUO kidneys from the marmosets. Polyamide effectively improved CsA- and UUO-associated nephropathy, indicating its potential application in the prevention of renal fibrosis in progressive renal diseases. MDPI 2019-09-01 /pmc/articles/PMC6749436/ /pubmed/31480595 http://dx.doi.org/10.3390/molecules24173178 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Otsuki, Masari Fukuda, Noboru Inoue, Takashi Mineshige, Takayuki Otsuki, Tomoyasu Horikoshi, Shu Endo, Morito Abe, Masanori Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset |
title | Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset |
title_full | Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset |
title_fullStr | Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset |
title_full_unstemmed | Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset |
title_short | Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset |
title_sort | preclinical study of dna-recognized peptide compound pyrrole-imidazole polyamide targeting human tgf-β1 promoter for progressive renal diseases in the common marmoset |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749436/ https://www.ncbi.nlm.nih.gov/pubmed/31480595 http://dx.doi.org/10.3390/molecules24173178 |
work_keys_str_mv | AT otsukimasari preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT fukudanoboru preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT inouetakashi preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT mineshigetakayuki preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT otsukitomoyasu preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT horikoshishu preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT endomorito preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset AT abemasanori preclinicalstudyofdnarecognizedpeptidecompoundpyrroleimidazolepolyamidetargetinghumantgfb1promoterforprogressiverenaldiseasesinthecommonmarmoset |